Resolving A Controversy: Inhibition Of Cardiac Ryanodine Receptors Is The Principal Mechanism Of Antiarrhythmic Action Of Flecainide In Catecholaminergic Polymorphic Ventricular Tachycardia
Circulation(2020)
Abstract
Rationale: The class Ic antiarrhythmic drug flecainide prevents ventricular tachyarrhythmia in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a disease caused by hypera...
MoreTranslated text
Key words
cardiac ryanodine receptors,antiarrhythmic action,flecainide
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined